SHPH Shuttle Pharmaceuticals Hol...

Nasdaq shuttlepharma.com


$ 2.00 $ 0.01 (0.5 %)    

Thursday, 20-Nov-2025 09:45:30 EST
QQQ $ 613.04 $ 1.37 (0.22 %)
DIA $ 468.12 $ 1.39 (0.3 %)
SPY $ 674.80 $ 1.90 (0.28 %)
TLT $ 89.12 $ 0.13 (0.15 %)
GLD $ 376.61 $ 1.33 (0.35 %)
$ 1.98
$ 1.99
$ 2.00 x 100
$ 2.12 x 100
$ 2.00 - $ 2.00
$ 1.85 - $ 25.25
31,455
na
3.17M
$ 5.99
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-13-2025 09-30-2025 10-Q
2 08-12-2025 06-30-2025 10-Q
3 05-08-2025 03-31-2025 10-Q
4 02-26-2025 12-31-2024 10-K
5 11-13-2024 09-30-2024 10-Q
6 09-04-2024 06-30-2024 10-Q
7 05-13-2024 03-31-2024 10-Q
8 03-21-2024 12-31-2023 10-K
9 11-13-2023 09-30-2023 10-Q
10 08-14-2023 06-30-2023 10-Q
11 05-25-2023 03-31-2023 10-Q
12 03-15-2023 12-31-2022 10-K
13 11-14-2022 09-30-2022 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 shuttle-pharmaceuticals-q3-eps-105-up-from-3975-yoy

Shuttle Pharmaceuticals (NASDAQ:SHPH) reported quarterly losses of $(1.05) per share. This is a 97.36 percent increase over los...

 shuttle-pharma-executes-non-binding-loi-to-acquire-moleculeai-and-its-platform-for-10m-in-combination-of-cash-and-common-shares

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) ("Shuttle Pharma" or the "Company"), a discovery and devel...

 shuttle-pharmaceuticals-announces-non-binding-loi-to-purchase-moleculeai-for-10m

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) ("Shuttle Pharma" or the "Company"), a discovery and devel...

 shuttle-pharmaceuticals-q2-eps-329-up-from-2412-yoy

Shuttle Pharmaceuticals (NASDAQ:SHPH) reported quarterly losses of $(3.29) per share. This is a 86.36 percent increase over los...

 shuttle-pharmaceuticals-has-been-granted-us-patent-number-12357650-titled-methods-and-compositions-for-cancer-therapies-that-include-delivery-of-halogenated-thymidines-and-thymidine-phosphorlylase-inhibitors-in-combination-with-radiation

https://ppubs.uspto.gov/pubwebapp/external.html?q=(12357650).pn

 shuttle-pharmaceuticals-announces-pricing-of-425m-private-placement-at-a-purchase-price-of-360-per-share

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) ("Shuttle Pharma" or the "Company"), a discovery and devel...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION